Showing results (511-520 of 587) with videos related to

Sort By:
Pageof 59
Hepatology (Baltimore, Md.)|September 20, 2017
Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trialDavid Wyles, Fred Poordad, Stanley Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 11, 2018
Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary CholangitisGeorge Cholankeril, Humberto C Gonzalez, Sanjaya K Satapathy, et al.
Journal of Hepatology|April 4, 2020
DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohortElizabeth C Verna, Giuseppe Morelli, Norah A Terrault, et al.
Liver Cancer|November 30, 2018
Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma TreatmentPi-Yi Chang, Chun-Chieh Huang, Chao-Hung Hung, et al.
Optics Letters|May 3, 2008
Parallel confocal detection of single molecules in real timePaul M Lundquist, Cheng F Zhong, Peiqian Zhao, et al.
Journal of Cardiovascular Electrophysiology|May 9, 2008
The important role of pulmonary vein carina ablation as an adjunct to circumferential pulmonary vein isolationAmeya R Udyavar, Shih-Lin Chang, Ching-Tai Tai, et al.
Acta Cardiologica Sinica|February 5, 2019
Changing Practice Pattern of Acute Coronary Syndromes in Taiwan from 2008 to 2015Yi-Heng Li, Yu-Wei Chiu, Jun-Jack Cheng, et al.
Mayo Clinic Proceedings|March 6, 2017
Prehospital Predictors of Initial Shockable Rhythm in Out-of-Hospital Cardiac Arrest: Findings From the Taichung Sudden Unexpected Death Registry (THUNDER)Yen-Nien Lin, Shih-Sheng Chang, Lee-Min Wang, et al.
Heart Rhythm|August 5, 2008
Right atrial substrate properties associated with age in patients with typical atrial flutterJin-Long Huang, Ching-Tai Tai, Yenn-Jiang Lin, et al.
Journal of Hepatology|April 22, 2014
Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: meta-analysis of 5 trialsJohn M Vierling, Stefan Zeuzem, Fred Poordad, et al.
Pageof 59